{
  "success": true,
  "pagesUsed": [
    2,
    8,
    16
  ],
  "modelUsed": "gemini-3-flash-preview",
  "narrative": {
    "narrativeContents": [
      {
        "id": "nc_1",
        "name": "TRIAL SUMMARY",
        "text": "TRIAL SUMMARY",
        "order": 0,
        "instanceType": "NarrativeContent",
        "sectionNumber": "1.0",
        "sectionTitle": "TRIAL SUMMARY",
        "sectionType": {
          "id": "c3cce7e5-fc0d-4f8a-80e4-36a97fdb4e22",
          "code": "Synopsis",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Synopsis",
          "instanceType": "Code"
        }
      },
      {
        "id": "nc_2",
        "name": "TRIAL DESIGN",
        "text": "TRIAL DESIGN",
        "order": 1,
        "instanceType": "NarrativeContent",
        "sectionNumber": "2.0",
        "sectionTitle": "TRIAL DESIGN",
        "sectionType": {
          "id": "b3837f74-ea25-4999-8c74-fe236aba6cb4",
          "code": "Study Design",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Study Design",
          "instanceType": "Code"
        },
        "childIds": [
          "nci_2_1",
          "nci_2_2"
        ]
      },
      {
        "id": "nc_3",
        "name": "OBJECTIVE(S) & HYPOTHESIS(ES)",
        "text": "OBJECTIVE(S) & HYPOTHESIS(ES)",
        "order": 2,
        "instanceType": "NarrativeContent",
        "sectionNumber": "3.0",
        "sectionTitle": "OBJECTIVE(S) & HYPOTHESIS(ES)",
        "sectionType": {
          "id": "8d03f76c-c4fe-4baf-a368-d85f0e117c0c",
          "code": "Objectives",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Objectives",
          "instanceType": "Code"
        },
        "childIds": [
          "nci_3_1",
          "nci_3_2",
          "nci_3_3"
        ]
      },
      {
        "id": "nc_4",
        "name": "BACKGROUND & RATIONALE",
        "text": "BACKGROUND & RATIONALE",
        "order": 3,
        "instanceType": "NarrativeContent",
        "sectionNumber": "4.0",
        "sectionTitle": "BACKGROUND & RATIONALE",
        "sectionType": {
          "id": "178b0fab-1705-4938-a273-66f347331b85",
          "code": "Introduction",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Introduction",
          "instanceType": "Code"
        },
        "childIds": [
          "nci_4_1",
          "nci_4_2",
          "nci_4_3",
          "nci_4_4",
          "nci_4_5",
          "nci_4_6",
          "nci_4_7",
          "nci_4_8"
        ]
      },
      {
        "id": "nc_5",
        "name": "LIST OF REFERENCES",
        "text": "LIST OF REFERENCES",
        "order": 4,
        "instanceType": "NarrativeContent",
        "sectionNumber": "11.0",
        "sectionTitle": "LIST OF REFERENCES",
        "sectionType": {
          "id": "9e972a86-ef4f-4590-82ae-7b22ea876115",
          "code": "References",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "References",
          "instanceType": "Code"
        }
      },
      {
        "id": "nc_6",
        "name": "APPENDICES",
        "text": "APPENDICES",
        "order": 5,
        "instanceType": "NarrativeContent",
        "sectionNumber": "12.0",
        "sectionTitle": "APPENDICES",
        "sectionType": {
          "id": "11e371a3-a134-4830-90b9-254bc9d9afe1",
          "code": "Appendix",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Appendix",
          "instanceType": "Code"
        },
        "childIds": [
          "nci_6_1",
          "nci_6_2",
          "nci_6_3",
          "nci_6_4",
          "nci_6_5",
          "nci_6_6",
          "nci_6_7"
        ]
      },
      {
        "id": "nc_7",
        "name": "SIGNATURES",
        "text": "SIGNATURES",
        "order": 6,
        "instanceType": "NarrativeContent",
        "sectionNumber": "13.0",
        "sectionTitle": "SIGNATURES",
        "sectionType": {
          "id": "77ff63aa-1d76-4e15-8780-c6d6afc73d89",
          "code": "Other",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Other",
          "instanceType": "Code"
        }
      }
    ],
    "narrativeContentItems": [
      {
        "id": "nci_2_1",
        "name": "Trial Design",
        "text": "",
        "order": 0,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "2.1",
        "sectionTitle": "Trial Design"
      },
      {
        "id": "nci_2_2",
        "name": "Trial Diagram",
        "text": "",
        "order": 1,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "2.2",
        "sectionTitle": "Trial Diagram"
      },
      {
        "id": "nci_3_1",
        "name": "Primary Objective(s) & Hypothesis(es)",
        "text": "",
        "order": 0,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "3.1",
        "sectionTitle": "Primary Objective(s) & Hypothesis(es)"
      },
      {
        "id": "nci_3_2",
        "name": "Secondary Objective(s) & Hypothesis(es)",
        "text": "",
        "order": 1,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "3.2",
        "sectionTitle": "Secondary Objective(s) & Hypothesis(es)"
      },
      {
        "id": "nci_3_3",
        "name": "Exploratory Objectives",
        "text": "",
        "order": 2,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "3.3",
        "sectionTitle": "Exploratory Objectives"
      },
      {
        "id": "nci_4_1",
        "name": "Background",
        "text": "",
        "order": 0,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "4.1",
        "sectionTitle": "Background"
      },
      {
        "id": "nci_4_2",
        "name": "Pharmaceutical and Therapeutic Background",
        "text": "",
        "order": 1,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "4.1.1",
        "sectionTitle": "Pharmaceutical and Therapeutic Background"
      },
      {
        "id": "nci_4_3",
        "name": "Pre-clinical and Clinical Trials",
        "text": "",
        "order": 2,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "4.1.2",
        "sectionTitle": "Pre-clinical and Clinical Trials"
      },
      {
        "id": "nci_4_4",
        "name": "Rationale",
        "text": "",
        "order": 3,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "4.2",
        "sectionTitle": "Rationale"
      },
      {
        "id": "nci_4_5",
        "name": "Rationale for the Trial and Selected Subject Population",
        "text": "",
        "order": 4,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "4.2.1",
        "sectionTitle": "Rationale for the Trial and Selected Subject Population"
      },
      {
        "id": "nci_4_6",
        "name": "Rationale for Dose Selection/Regimen/Modification",
        "text": "",
        "order": 5,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "4.2.2",
        "sectionTitle": "Rationale for Dose Selection/Regimen/Modification"
      },
      {
        "id": "nci_4_7",
        "name": "Rationale for Endpoints",
        "text": "",
        "order": 6,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "4.2.3",
        "sectionTitle": "Rationale for Endpoints"
      },
      {
        "id": "nci_4_8",
        "name": "Biomarker Research",
        "text": "",
        "order": 7,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "4.2.4",
        "sectionTitle": "Biomarker Research"
      },
      {
        "id": "nci_6_1",
        "name": "Merck Code of Conduct for Clinical Trials",
        "text": "",
        "order": 0,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "12.1",
        "sectionTitle": "Merck Code of Conduct for Clinical Trials"
      },
      {
        "id": "nci_6_2",
        "name": "Collection and Management of Specimens for Future Biomedical Research",
        "text": "",
        "order": 1,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "12.2",
        "sectionTitle": "Collection and Management of Specimens for Future Biomedical Research"
      },
      {
        "id": "nci_6_3",
        "name": "Understanding the Intent, Scope and Public Health Benefits of Exploratory Biomarker Research",
        "text": "",
        "order": 2,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "12.3",
        "sectionTitle": "Understanding the Intent, Scope and Public Health Benefits of Exploratory Biomarker Research"
      },
      {
        "id": "nci_6_4",
        "name": "Response Evaluation Criteria in Solid Tumors",
        "text": "",
        "order": 3,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "12.4",
        "sectionTitle": "Response Evaluation Criteria in Solid Tumors"
      },
      {
        "id": "nci_6_5",
        "name": "ECOG Performance Status",
        "text": "",
        "order": 4,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "12.5",
        "sectionTitle": "ECOG Performance Status"
      },
      {
        "id": "nci_6_6",
        "name": "Common Terminology Criteria for Adverse Events",
        "text": "",
        "order": 5,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "12.6",
        "sectionTitle": "Common Terminology Criteria for Adverse Events"
      },
      {
        "id": "nci_6_7",
        "name": "List of Abbreviations",
        "text": "",
        "order": 6,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "12.7",
        "sectionTitle": "List of Abbreviations"
      }
    ],
    "abbreviations": [
      {
        "id": "abbr_1",
        "abbreviatedText": "GEP",
        "expandedText": "Immune-related Gene Expression Profile",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_2",
        "abbreviatedText": "irRECIST",
        "expandedText": "Immune-related RECIST",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_3",
        "abbreviatedText": "IRBs",
        "expandedText": "Institutional Review Boards",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_4",
        "abbreviatedText": "IECs",
        "expandedText": "Independent Ethics Committees",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_5",
        "abbreviatedText": "ECOG",
        "expandedText": "Eastern Cooperative Oncology Group",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_6",
        "abbreviatedText": "AE",
        "expandedText": "adverse event",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_7",
        "abbreviatedText": "SAE",
        "expandedText": "Serious adverse events",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_8",
        "abbreviatedText": "CR",
        "expandedText": "complete response",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_9",
        "abbreviatedText": "EGJ",
        "expandedText": "esophagogastric junction",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_10",
        "abbreviatedText": "PD-L1",
        "expandedText": "Programmed Death-Ligand 1",
        "instanceType": "Abbreviation"
      }
    ],
    "summary": {
      "sectionCount": 7,
      "itemCount": 20,
      "abbreviationCount": 10
    },
    "studyDefinitionDocument": {
      "id": "sdd_1",
      "name": "MK-3475-181-06 Final Protocol: A randomized, multi-center, open-label trial of pembrolizumab (MK-3475) versus the investigator’s choice of paclitaxel, docetaxel, or irinotecan in subjects with advanced/metastatic adenocarcinoma or squamous cell carcinoma of the esophagus, or advanced/metastatic Siewert type I adenocarcinoma of the esophagogastric junction (EGJ)",
      "documentType": "Protocol",
      "language": "en",
      "instanceType": "StudyDefinitionDocument",
      "version": "181-06",
      "versionDate": "25-Jun-2021",
      "contentIds": [
        "nc_1",
        "nc_2",
        "nc_3",
        "nc_4",
        "nc_5",
        "nc_6",
        "nc_7"
      ]
    }
  },
  "rawResponse": {
    "abbreviations": {
      "abbreviations": [
        {
          "abbreviation": "GEP",
          "expansion": "Immune-related Gene Expression Profile"
        },
        {
          "abbreviation": "irRECIST",
          "expansion": "Immune-related RECIST"
        },
        {
          "abbreviation": "IRBs",
          "expansion": "Institutional Review Boards"
        },
        {
          "abbreviation": "IECs",
          "expansion": "Independent Ethics Committees"
        },
        {
          "abbreviation": "ECOG",
          "expansion": "Eastern Cooperative Oncology Group"
        },
        {
          "abbreviation": "AE",
          "expansion": "adverse event"
        },
        {
          "abbreviation": "SAE",
          "expansion": "Serious adverse events"
        },
        {
          "abbreviation": "CR",
          "expansion": "complete response"
        },
        {
          "abbreviation": "EGJ",
          "expansion": "esophagogastric junction"
        },
        {
          "abbreviation": "PD-L1",
          "expansion": "Programmed Death-Ligand 1"
        }
      ]
    },
    "structure": {
      "document": {
        "title": "MK-3475-181-06 Final Protocol: A randomized, multi-center, open-label trial of pembrolizumab (MK-3475) versus the investigator’s choice of paclitaxel, docetaxel, or irinotecan in subjects with advanced/metastatic adenocarcinoma or squamous cell carcinoma of the esophagus, or advanced/metastatic Siewert type I adenocarcinoma of the esophagogastric junction (EGJ)",
        "version": "181-06",
        "versionDate": "25-Jun-2021"
      },
      "sections": [
        {
          "number": "1.0",
          "title": "TRIAL SUMMARY",
          "type": "Synopsis"
        },
        {
          "number": "2.0",
          "title": "TRIAL DESIGN",
          "type": "Study Design",
          "subsections": [
            {
              "number": "2.1",
              "title": "Trial Design"
            },
            {
              "number": "2.2",
              "title": "Trial Diagram"
            }
          ]
        },
        {
          "number": "3.0",
          "title": "OBJECTIVE(S) & HYPOTHESIS(ES)",
          "type": "Objectives",
          "subsections": [
            {
              "number": "3.1",
              "title": "Primary Objective(s) & Hypothesis(es)"
            },
            {
              "number": "3.2",
              "title": "Secondary Objective(s) & Hypothesis(es)"
            },
            {
              "number": "3.3",
              "title": "Exploratory Objectives"
            }
          ]
        },
        {
          "number": "4.0",
          "title": "BACKGROUND & RATIONALE",
          "type": "Introduction",
          "subsections": [
            {
              "number": "4.1",
              "title": "Background"
            },
            {
              "number": "4.1.1",
              "title": "Pharmaceutical and Therapeutic Background"
            },
            {
              "number": "4.1.2",
              "title": "Pre-clinical and Clinical Trials"
            },
            {
              "number": "4.2",
              "title": "Rationale"
            },
            {
              "number": "4.2.1",
              "title": "Rationale for the Trial and Selected Subject Population"
            },
            {
              "number": "4.2.2",
              "title": "Rationale for Dose Selection/Regimen/Modification"
            },
            {
              "number": "4.2.3",
              "title": "Rationale for Endpoints"
            },
            {
              "number": "4.2.4",
              "title": "Biomarker Research"
            }
          ]
        },
        {
          "number": "11.0",
          "title": "LIST OF REFERENCES",
          "type": "References"
        },
        {
          "number": "12.0",
          "title": "APPENDICES",
          "type": "Appendix",
          "subsections": [
            {
              "number": "12.1",
              "title": "Merck Code of Conduct for Clinical Trials"
            },
            {
              "number": "12.2",
              "title": "Collection and Management of Specimens for Future Biomedical Research"
            },
            {
              "number": "12.3",
              "title": "Understanding the Intent, Scope and Public Health Benefits of Exploratory Biomarker Research"
            },
            {
              "number": "12.4",
              "title": "Response Evaluation Criteria in Solid Tumors"
            },
            {
              "number": "12.5",
              "title": "ECOG Performance Status"
            },
            {
              "number": "12.6",
              "title": "Common Terminology Criteria for Adverse Events"
            },
            {
              "number": "12.7",
              "title": "List of Abbreviations"
            }
          ]
        },
        {
          "number": "13.0",
          "title": "SIGNATURES",
          "type": "Other"
        }
      ]
    }
  }
}